Scott Barrett

Scott Barrett, M.D. is an accomplished medical professional with extensive experience in oncology and clinical development. Currently serving as Chief Clinical Lead at Pathos since October 2025 and Chief Clinical Officer at ViridBio Solutions since January 2024, Scott Barrett has focused on advancing clinical trial strategies and regulatory compliance. Previous roles include Senior Vice President and Head of Clinical Development at Verastem Oncology and Chief Medical Officer at Immuneering Corporation. Scott Barrett's career also encompasses significant positions in clinical affairs at Incyte and Infinity Pharmaceuticals, and a solid foundation in medical oncology at Eisai and Johnson & Johnson. Scott Barrett's educational background includes a Doctor of Medicine degree from the University of Miami, a Bachelor of Arts from The Johns Hopkins University, and both a Medical Oncology Fellowship and Internal Medicine residency at prestigious institutions.